Breaking News

Stevanato Group Acquires Facility in Zhangjiagang

Plans to cement the area as a major manufacturing hub for biopharmaceutical innovation.

Author Image

By: Charlie Sternberg

Associate Editor

Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has acquired a facility in Zhangjiagang for a new plant where the company expects to begin renovations in spring 2022, as part of the latest phase of its expansion in China.   The new facility is located near the company’s drug containment solutions facility in the Jiangsu Zhangjiagang Economic and Technological Development Zone, help...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters